default author photo

Heinrich Haas

Neovac Ltd

Didcot

United Kingdom

SCHOLARLY PAPERS

2

DOWNLOADS

555

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Safety, Tolerability, and Immunogenicity of NeomiVac, a Next-Generation mRNA–Lipid Nanoparticle Vaccine Comprising a Novel Ionisable Lipid: A First-In-Human, Phase 1, Dose-Escalation Trial

Number of pages: 1 Posted: 28 Jan 2026
University of Oxford, University of Oxford, University of Oxford, University of Oxford, University of Oxford, University of Oxford, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford, University of Oxford, Neovac Ltd, Neovac Ltd, Neovac Ltd, Neovac Ltd, Neovac Ltd, Neovac Ltd, University of Oxford, University of Oxford, University of Oxford, University of Oxford, University of Oxford, Neovac Ltd, Neovac Ltd, Neovac Ltd, Neovac Ltd, University of Oxford, University of Oxford - The Jenner Institute, Neovac Ltd, University of Oxford - Wellcome Trust Centre for Human Genetics, University of Oxford - Peter Medawar Building for Pathogen Research and University of Oxford - Oxford Vaccine Group
Downloads 492 (144,435)

Abstract:

Loading...

mRNA vaccine, novel lipid nanoparticle vaccine (LNP), reactogenicity, immunogenicity, SARS-CoV2

2.

Molecular Localization and Exchange Kinetics in Pharmaceutical Liposome and Mrna Nanoparticle Products Determined by Small Angle X-Ray Scattering and Pulsed Field Gradient Nmr Diffusion Measurements

Number of pages: 33 Posted: 13 Feb 2024
Neovac Ltd, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Münster and University of Münster
Downloads 63 (933,592)

Abstract:

Loading...

Pulsed field gradient NMR diffusion, DOSY, Liposomes, mRNA, lipoplexes, LNPs, Nanoparticles, SAXS